School of Medicine

Girls with a rare genetic disorder caused by mutations in a gene known as Nf1 are much more likely to lose their vision than boys with mutations in the same gene. And now, researchers at Washington University School of Medicine in St. Louis believe they know why: Female sex hormones activate immune cells that damage the nerves necessary for vision.

The son of Washington University Nobel laureates Carl and Gerty Cori has given the Nobel Prizes his parents were awarded in 1947 to the university. They can be seen at the Becker Medical Library.

Rick W. Wright, MD, the Jerome J. Gilden Distinguished Professor of Orthopaedic Surgery at Washington University School of Medicine in St. Louis, has been chosen as second president-elect by members of the American Orthopaedic Association.

Surgery can restore vision in patients who have suffered hemorrhaging in the eye after a traumatic brain injury, even if the operation doesn’t occur until several months after the injury, according to a small study from vision researchers at Washington University School of Medicine in St. Louis.

Kelly R. Monk, associate professor of developmental biology at Washington University School of Medicine in St. Louis, has received a Harry Weaver Neuroscience Scholar Award from the National Multiple Sclerosis Society.

While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer. The pathway, known as the nicotinamide adenine dinucleotide (NAD+) pathway, is overactive in a deadly form of brain cancer known as glioblastoma, according to a study by researchers at Washington University School of Medicine in St. Louis.

Li Ding, associate professor at the School of Medicine, is a cryptographer of sorts. She develops computational tools to study the genetics of cancer.

Researchers at Washington University School of Medicine in St. Louis are launching a study aimed at identifying effective treatment methods for seniors with depression that does not respond to standard medications.

George F. Van Hare III, MD, director of the Division of Pediatric Cardiology at Washington University School of Medicine in St. Louis, has been named president-elect of the Heart Rhythm Society, a global research and education group focused on cardiac rhythm disorders.

Patients with the most lethal form of acute myeloid leukemia (AML) – based on genetic profiles of their cancers – typically survive for only four to six months after diagnosis, even with aggressive chemotherapy. But new research led by the School of Medicine indicates that such patients, paradoxically, may live longer if they receive a milder chemotherapy drug.